The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carrying gemicitabine and the pseudo-peptide NucAnt.

MLA

Sanhaji, Mourad, et al. “The Phenotype of Target Pancreatic Cancer Cells Influences Cell Death by Magnetic Hyperthermia with Nanoparticles Carrying Gemicitabine and the Pseudo-Peptide NucAnt.” Nanomedicine: Nanotechnology, Biology & Medicine, vol. 20, Aug. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.nano.2018.12.019.

APA

Sanhaji, M., Göring, J., Couleaud, P., Aires, A., Cortajarena, A. L., Courty, J., Prina-Mello, A., Stapf, M., Ludwig, R., Volkov, Y., Latorre, A., Somoza, Á., Miranda, R., & Hilger, I. (2019). The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carrying gemicitabine and the pseudo-peptide NucAnt. Nanomedicine: Nanotechnology, Biology & Medicine, 20, N.PAG. https://doi.org/10.1016/j.nano.2018.12.019

Chicago

Sanhaji, Mourad, Julia Göring, Pierre Couleaud, Antonio Aires, Aitziber L. Cortajarena, José Courty, Adriele Prina-Mello, et al. 2019. “The Phenotype of Target Pancreatic Cancer Cells Influences Cell Death by Magnetic Hyperthermia with Nanoparticles Carrying Gemicitabine and the Pseudo-Peptide NucAnt.” Nanomedicine: Nanotechnology, Biology & Medicine 20 (August): N.PAG. doi:10.1016/j.nano.2018.12.019.